In a comparative study evaluating SGLT2 inhibitors and GLP-1 medications, the former drug class was associated with lower ...

A new study confirms that people taking GLP-1s are more likely to experience hair loss. The good news? It’s probably ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity ...

Several co-hosts of 'The View' have now discussed their GLP-1 usage, including Joy Behar. Here's what to know.

There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...

News and commentary from the endocrinology world ...

Could preserved vision be part of the growing list of health benefits associated with GLP-1 drug use? New research suggests ...

Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

A new review finds no convincing evidence that drugs like Ozempic raise people's risk of common thyroid cancers.

The guide to how much GLP-1 medications cost, including Ozempic, Wegovy, and Zepbound.

By Sriparna Roy and Juveria Tabassum Feb 18 (Reuters) - Global food and beverage companies from PepsiCo to Coca-Cola are ...